• 대한두경부종양학회지
• /
• 제17권2호
• /
• pp.169-173
• /
• 2001

Objectives: The p53 tumor suppressor gene encodes a nuclear transcription factor that is critical regulator of cell growth and proliferation through its action in cell-cycle checkpoint control. The wide variety of stressful stmuli which include DNA damage, hypoxia, heat shock, metabolic changes activate the p53 protein, which in turn drives a series of events that culminate either in cell cycle arrest or apoptosis. Mutations of the p53 gene is the most common genetic alteration in human cancer. This gene is altered in approximately 40-60% of head and neck cancers. Whereas the wild-type form of the p53 protein plays a central role in cell-cycle control in response to DNA damage, most of the mutant forms are unable to do so. The high levels of p53 protein expression in tissues are related to the increased cellular proliferative activity and may be associated with the poor clinical outcome. To determine whether the expression of the p53 protein has prognostic significance and is associated with patterns of treatment failure in head and neck squamous cell carcinoma (HNSCC), We analyzed p53 overexpression in 40 cases of HNSCC. Materials and Methods: Immunohistochemical analysis with a monoclonal antibody (DO7) specific for p53 protein was used to detect expression of the protein in formalin-fixed, paraffin-embedded tumor samples from 40 HNSCC. We evaluated p53 protein expression and analyzed the relationship between the p53 overexpression and age, sex, primary tumor site, stage, survival rate, recurrence. All reported P values resulted from two-sided statistical tests. Results: Overexpression of p53 was detected in 20 cases(50%) among 40 cases of HNSCC. The p53 overexpression was not associated with age, sex, primary tumor site, stage, recurrence and survival rate. Conclusions: In our results, p53 was not significant prognostic factor in HNSCC. Based on many previous studies, It is evident that p53 has a certain role in tumorigenesis of HNSCC. So, the further study is needed to evaluate the prognostic significance of p53 in HNSCC.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권4호
• /
• pp.1599-1603
• /
• 2015

Background: Epigenetic silencing of tumor suppressor genes due to promoter hypermethylation is one of the frequent mechanisms observed in cancers. Hypermethylation of several tumor suppressor genes involved in cell cycle regulation has been reported in many types of tumors including oral squamous cell carcinomas. LATS1 (Large Tumor Suppressor, isoform 1) is a novel tumor suppressor gene that regulates cell cycle progression by forming complexes with the cyclin dependent kinase, CDK1. Promoter hypermethylation of the LATS1 gene has been observed in several carcinomas and also has been linked with prognosis. However, the methylation status of LATS1 in oral squamous cell carcinomas is not known. As oral cancer is one of the most prevalent forms of cancer in India, the present study was designed to investigate the methylation status of LATS1 promoter and associate it with histopathological findings in order to determine any associations of the genetic status with stage of differentiation. Materials and Methods: Tumor chromosomal DNA isolated from biopsy tissues of thirteen oral squamous cell carcinoma biopsy tissues were subjected to digestion with methylation sensitive HpaII enzyme followed by amplification with primers flanking CCGG motifs in promoter region of LATS1 gene. The PCR amplicons were subsequently subjected to agarose gel electrophoresis along with undigested amplification control. Results: HpaII enzyme based methylation sensitive PCR identified LATS1 promoter hypermethylation in seven out of thirteen oral squamous cell carcinoma samples. Conclusions: The identification of LATS1 promoter hypermethylation in seven oral squamous cell carcinoma samples (54%), which included one sample with epithelial dysplasia, two early invasive and one moderately differentiated lesions indicates that the hypermethylation of this gene may be one of the early event during carcinogenesis. To the best of our knowledge, this is the first study to have explored and identified positive association between LATS1 promoter hypermethylation with histopathological features in oral squamous cell carcinomas.

• 한국환경성돌연변이발암원학회지
• /
• 제9권1호
• /
• pp.23-32
• /
• 1989

Chinese hamster ovary (CHO)-K1 cells echibited a differential sensitivity in the process of DNA repair synthesis induced by ethyl methanesulfonate (EMS) or bleomycin (BLM) in relation to cell cycle. Two assays were employed in this study: alkaline elution and unscheduled DNA synthesis. The post-treat-ment with aphidicolin (APC), an inhibitor of DNA polymerase alpha, inhibited DNA repair synthesis induced by EMS in G2 phase, while APC did not show any effect on BLM-induced DNA repair synthesis in all phases. On the other hands, the 2', 3'-dideoxythymidine (ddTTP), an inhibitor of DNA polymerase beta, inhibited DNA repair synthesis induced by EMS or BLM in both of G1 and G2 phases. These results suggested that the involvement of DNA polymerase alpha and beta in DNA repair was dependent on cell stage or used chemical agent.

• 대한의생명과학회지
• /
• 제23권3호
• /
• pp.290-294
• /
• 2017

Metformin or sodium salicylate is known to induce apoptosis and G0/G1 phase arrest in a variety of cancer cells. However, the anti-cancer effects of the combined treatments for these drugs-induced apoptosis are yet unclear. Here, we found that the combined treatment of metformin and sodium salicylate increased the efficacy of chemotherapeutics against breast cancer cells. These combined drugs significantly inhibited cellular proliferation and induced apoptosis at an earlier stage in human MCF-7 breast cancer cells. Also, co-treatments of metformin and sodium salicylate induced G1 cell cycle arrest in MCF-7 cells more effectively than either agent alone. Taken together, these results demonstrate that dual metformin/sodium salicylate treatment prevents proliferation of MCF-7 cells by inducing apoptosis and G1 cell cycle arrest.

• Molecules and Cells
• /
• 제43권2호
• /
• pp.182-187
• /
• 2020

When cells are stimulated by growth factors, they make a critical choice in early G₁ phase: proceed forward to S phase, remain in G₁, or revert to G₀ phase. Once the critical decision is made, cells execute a fixed program independently of extracellular signals. The specific stage at which the critical decision is made is called the restriction point or R-point. The existence of the R-point raises a major question: what is the nature of the molecular machinery that decides whether or not a cell in G₁ will continue to advance through the cell cycle or exit from the cell cycle? The R-point program is perturbed in nearly all cancer cells. Therefore, exploring the nature of the R-point decision-making machinery will provide insight into how cells consult extracellular signals and intracellular status to make an appropriate R-point decision, as well into the development of cancers. Recent studies have shown that expression of a number of immediate early genes is associated with the R-point decision, and that the decision-making program constitutes an oncogene surveillance mechanism. In this review, we briefly summarize recent findings regarding the mechanisms underlying the context-dependent R-point decision.

• 한국수정란이식학회지
• /
• 제10권1호
• /
• pp.73-82
• /
• 1995

large scale production of cloned embryos requires the technology of multiple generation nuclear transplantation(NT) using NT embryos as the subsequent donor nuclei. The purposes of this study were producing the second generation cloned rabbit embryos, and also to determine the electrofusion rate and in vitro developmental potential comparatively in the cloned embryos of the first and second NT generation. The embryos of 16-cell stage were collected from the mated does by flushing oviducts with Dulbecco's phosphate buffered saline(D-PBS) containing 10% fetal calf serum(FCS) at 47 hours after hCG injection In the first generation NT, the nuclear donor embryos were synchronized in the phase of Gi /S transition of 32-cell stage. The first generation NT embryos which were developed to 8-cell were synchronized in Gi /S transition phase of the following 16-cell stage and used as donor nuclei for second generation Synchronization of the cell cycle of blastomeres was induced, first, using an inhibitor of microtuble polymerization, colcemid for 10 hours to arrest blastomeres in M phase, and secondly, using a DNA synthesis inhibitor, aphidicolin for 1.5 to 2 hours to arrest them in Gi /S transition boundary. The recipient cytoplasms were obtained by removing the nucleus and the first polar body from the oocytes collected at 14 hours after hCG injection. The separated donor blastomeres were injected into the enucleated recipient oocytes by micromanipulation and were electrofused by electrical stimulation of three pulses for 60 $\mu$sec at 1.25 kV /cm in 0.28 M rnannitol solution The fused oocytes were co-cultured with a monolayer of rabbit oviductal epithelial cells in M-199 solution containing 10% FCS for 120 hours at 39$^{\circ}C$ in a 5% $CO_2$ incubator. Following in vitro culture of the first and second generation cloned embryos to blastocyst stage, they were stained with Hoechst 33342 dye for counting the number of blastomeres by fluorescence microscopy. The results obtained were summarized as follows: 1. The electrofusion rate was found to be similar as 79.4 and 91.5% in the first and second generation NT rabbit embryos, respectively. 2. The in vitro developmental potential to blastocyst stage of the second generation NT embryos (23.3%) was found significantly(p<0.05) lower, compared with that of the first generation NT embryos (56.8%). 3. The mean blastomeres counts of embryos developed to blastosyst stage following in vitro culture for 120 hours and also their daily cell cycles during the culture period were decreased significantly (p<0.05) to 104.3 cells and 1.33 cylces in the second NT generation, compoared with 210.4 cells and 1.54 cycles in the first NT generation, respectively.

• 한국수정란이식학회지
• /
• 제12권2호
• /
• pp.171-179
• /
• 1997

The objectives of the present study were improvements in the efficiency of developmental rates to morula and blastocyst stages to produce a large number of genetically identical nuclear transplant embryos. The oocytes collected from slaughterhouse ovaries were matured for 24 h and then enucleated and cultured to allow cytoplasmic maturation and gain activation competence. And then the donor embryos were treated for 12 h with 10 $\pi$g /ml nocodazole and 7.5 $\pi$g /ml cytochalasin B to synchronize the cell cycle stage at 26 h after the onset of culture. The blastomeres were transferred into the perivitelline space of the enucleated nocytes and blastomeres and oocytes were fused by electrofusion. The cloned embryos were then cultured in various conditions to allow further development. The age of the recipient(30 vs 40 h) had no significant effect on the fusion rates(82.4 vs 82.1%) and the developmental rates to morula /blastocyst(9.8 vs 11.0%). Effect of Nocodazole treatment on the donor cell cyle synchronization to improve the developmental rates of bovine nuclear transplant embryos was significantly higher than control group(21.4 vs 10.1%, p<0.05). Significant differences were in the percentage of fusion rates(72.9,77.1vs 61.9%) in three types of fusion medium(PBS(+), mannitol and sucrose, p<0.01). The developmental rates of bovine nuclear transplant embryos appeared to be highest in mSOF medium under 5% 0$_2$ condition, but no significant differences were found when compared with TCM199-BOEC and mSOF under two different oxygen ratio(5 and 20%).

• 한국수정란이식학회지
• /
• 제27권4호
• /
• pp.193-203
• /
• 2012

The development of embryos reconstructed by nuclear transfer is dependent upon numerous factors including the type of recipient cell, method of enucleation, the type of donor cell, method of reconstruction, activation, the cell cycle stage of both the donor nucleus and the recipient cytoplasm and the method of culture of the reconstructed embryos. Many of these points which have been reviewed extensively elsewhere (Sun and Moor, 1995; Colman, 1999; Oback and Wells, 2002; Renard et al., 2002; Galli et al., 2003b), here we will concentrate on main area, the production of suitable cytoplast and nuclear donor, nuclear-cytoplasmic coordination, oocyte activation, culture of reconstructed embryos, and the effects that this may have on development.

• 한국발생생물학회지:발생과생식
• /
• 제13권1호
• /
• pp.25-33
• /
• 2009

본 연구는 흰넓적다리 붉은쥐(Apodemus speciosus peninsulae)의 세정관 상피주기와 정자세포의 발달 단계를 광학 현미경을 사용하여 조사하였다. 세정관 상피주기는 정모세포의 분화단계와 정자세포의 발달단계를 기초로 하여 9 stages로 나누었다. Ad형 정원세포의 경우 모든 단계에서 관찰되었다. Ap형의 정원세포는 I 단계, In형의 정원세포는 II와 III 단계, B형의 정원세포는 IV 단계에서 관찰되었다. 제 1 감수분열의 전기에 있어서, 세사기는 V와 VI 단계, 접합기는 I 단계에서 부터 IX 단계까지, 후사기는 III와 VII 단계, 복사기는 VIII 단계에서 각각 관찰되었으며, 제 2정모세포의 경우는 IX 단계에서 나타났다. 정자세포의 발달단계는 정자세포의 머리 형태, 핵과 첨체의 발달, 세포질의 형태 변화를 기초로 하여 12 steps로 구분되어졌다. 본 연구의 결과, 흰넓적다리 붉은쥐(A. s. peninsulae)는 정원세포 및 정모세포 출현시기와 정자 발달 단계를 비교해 볼 때 근연종인 등줄쥐(A. agrarius coreae)와 매우 유사한 결과를 나타내었다. 본 연구에서 같은 유형의 세포가 출현하는 시기와 정자 형성에 따른 세대수는 종의 특성에 의한 것이라 생각되며, 이것은 종을 분류하는데 유용한 형질이라 여겨진다.

• 생명과학회지
• /
• 제15권2호
• /
• pp.253-260
• /
• 2005

인체 MCAK 단백질을 Escherichia. coli에서 재조합 단백질로 발현하였다. 이를 SDS-PAGE 후 electroelution으로 정제하고 항원으로 사용하여 rat에서 다클론성 항체생성을 유도한 결과, 생성된 항체는 Western blot analysis에 의해 인체 MCAK 단백질 (81 kDa)을 특이적으로 인식할 수 있었으며, Jurkat T cells과 293T cells에 있어서 MCAK 단백질의 대부분이 핵 내에 위치함을 확인할 수 있었다. 세포주기에 따른 MCAK 단백질의 발현양의 변화를 조사하기 위해, Jurkat T cells을 Hydroxy urea 또는 Nocodazole의 처리로 $G_{1}/S$ boundary 그리고 $G_{2}/M$ boundary에 blocking하고 이로부터 release 시키는 시간을 달리하여 다양한 세포주기상에 위치한 Jurkat T cells을 확보하였다. 각각의 Jurkat T cells로부터 cell lysate를 얻어서 Western blot analysis를 시도한 결과, MCAK 발현양은 S phase에서 가장 높았으며 MCAK의 SDS-PAGE상의 mobility가 81 kDa에서 84 kDa로 shift됨을 확인하였다. MCAK의 전기영동상의 mobility shift에 의한 slow moving $p84^{HsMCAK}$는 S phase 후반부터 나타나기 시작하며 $G_{2}/M$ phase에 최대였고 $G_{1}$, phase에서는 확인되지 않았다. 이는 세포주기에 따라 MCAK의 단백질의 인산화 양상이 달라짐을 시사한다. 생성된 항체를 이용한 Immunocytochemical analysis의 결과, 인체 MCAK 단백질은 세포주기의 interphase에서는 주로 중심체와 핵에 존재하며, M phase의 각 단계에 따라서 spindle pole, centromere, spindle fiber 또는 midbody에 존재함을 확인하였다. 이러한 연구 결과는 E. coli에서 발현된 재조합 HsMCAK 단백질을 항원으로 하여 rat에서 생산한 다클론성 항체가 HsMCAK 단백질을 특이적으로 인식할 수 있음과 또한 HsMCAK 단백질의 인산화를 나타내는 SDS-PAGE상의 mobility-shift가 $G_{2}/M$ phase에 최대에 도달하는 양상으로 세포주기에 따라 변동됨을 나타내며, HsMCAK의 인산화와 HsMCAK의 세포 내 위치간의 관련성을 시사한다. 아울러 이러한 연구결과는 hamster 및 Xenopus 등에서 주로 연구되고 있는 MCAK의 세포주기상의 주요기능이 인체세포에도 적용될 수 있음을 시사한다.